Human exonuclease 1 (hEXO1) has been implicated in DNA mismatch repair (MMR), replication, and recombination, but the nature of its interaction with these cellular processes is still ambiguous. We show that hEXO1 colocalizes with proliferating cell nuclear antigen (PCNA) at DNA replication sites and that the C-terminal region of hEXO1 is sufficient for this localization. We also show that both hMLH1-hPMS2 (MutLa) and hMLH1-hEXO1 complexes are formed in a reaction mixture containing all three proteins. Moreover, hEXO1 5 0 double-stranded exonuclease activity on a homoduplex substrate but not on a substrate containing a G/T mismatch was inhibited by complex formation with hMSH2-hMSH6 (MutSa) or MutLa. Taken together, the results support a model in which hEXO1 plays a role in events at the replication sites as well as a functional role in the MMR and/or recombination processes.
Introduction
Changes in the efficiency of DNA repair and recombination activities can be associated with a predisposition to cancer (Lengauer et al., 1998) . DNA mismatches arising through DNA replication errors, physical damage, or heteroduplex formation during genetic recombination become fixed in the genome as mutations (Buermeyer et al., 1999; Marra and Scha¨r, 1999; Hsieh, 2001) . The best understood MMR system is the Escherichia coli MMR pathway, and it is believed that the mechanism underlying human MMR is analogous (Modrich and Lahue, 1996; de Wind and Hays, 2001 ). In humans, mainly the initial mismatch recognition step has been characterized, whereas little is known about the downstream components, which in E. coli include an endonuclease (MutH), a helicase (UvrD), exonucleases (ExoI, ExoVII, ExoX, and RecJ), a single-stranded binding (Ssb) protein, a DNA polymerase (PolIII), and a DNA ligase. Putative downstream candidates in humans comprise exonuclease 1 (hEXO1), RPA, DNA polymerases d and e, and proliferating cell nuclear antigen (PCNA) (Buermeyer et al., 1999; Hsieh, 2001) . No major 3 0 to 5 0 exonuclease has been implicated in human MMR, but it has been suggested that the 3 0 to 5 0 proofreading activities of DNA polymerases d and e participate in the excision step of MMR Datta et al., 2000) . The human exonuclease 1 is homologous to S. cerevisiae Exo1 that belongs to the RAD2 Class III group of exonuclease-like enzymes (Szankasi and Smith, 1995; Digilio et al., 1996; Fiorentini et al., 1997; Tishkoff et al., 1997 Tishkoff et al., , 1998 Schmutte et al., 1998; Wilson et al., 1998; . Nucleases function in many cellular processes, including DNA repair, recombination, replication, and apoptosis. During recombination, exonucleases are thought to process break sites to generate single-stranded DNA that is the substrate for binding by homologous pairing proteins like the E. coli RecA. Yeast EXO1 is induced during meiosis (Wilson et al., 1998; Tsubouchi and Ogawa, 2000) , suggesting a role for the nuclease in meiotic recombination. Most meiotic recombination hot spots are cleaved by endonucleases during meiosis and the resulting double-stranded breaks are processed to leave 3 0 single-stranded tails (Cao et al., 1990; Sun et al., 1991) . Khazanehdari and Borts (2000) proposed that Exo1 plays an early role in establishing some recombination intermediates by generating single-stranded tails produced by the 5 0 to 3 0 double-stranded exonuclease activity of Exo1 . In addition, the Exo1 may have a minor role in the correction of large stretches of DNA mismatches that occur in heteroduplex DNA during meiotic recombination (Kirkpatrick et al., 2000) .
The human exonuclease 1 was first identified based on homology to the microbial counterparts (Schmutte et al., 1998; Tishkoff et al., 1998; Wilson et al., 1998) . hEXO1 exhibits an Mg 2 þ -dependent 5 0 to 3 0 exonuclease activity on single-and double-stranded DNA substrates as well as flap structure-specific endonuclease activity . The ability of hEXO1 to act on single-and double-stranded DNA substrates suggests that the exonuclease could act both at double-stranded ends to produce 3 0 single-stranded tails and to enlarge a nick to a single-stranded gap Genschel et al., 2002) . These enzymatic activities connect hEXO1 with three important cellular processes -DNA-replication, -recombination, and -repair. A role for hEXO1 in human MMR was inferred from its interaction with hMSH2 and hMLH1 (Tishkoff et al., , 1998 Schmutte et al., 1998 Schmutte et al., , 2001 Rasmussen et al., 2000a; Ja¨ger et al., 2001) . It was later shown that purified hEXO1 can complement cell extracts depleted for excision activities and that hEXO1 is involved in both 5 0 and 3 0 MMR activities (Genschel et al., 2002) . Further support for a role of hEXO1 in human MMR and cancer came from studies by Wu et al. (2001) , who identified germline mutations of hEXO1 in patients with hereditary nonpolyposis colorectal cancer (HNPCC). Several of the mutant proteins are defective in exonuclease activity as well as in their ability to interact with hMSH2 (Sun et al., 2002) . Recent genetic studies in S. cerevisiae have suggested that Exo1 plays a structural and/or catalytic role by stabilizing complexes that contain multiple MMR proteins (Sokolsky and Alani, 2000; Amin et al., 2001; Argueso et al., 2002) . However, the biological significance of the protein-protein interactions is unclear, since many proteins work by touching one another, either to form lasting multifunctional complexes or transient interactions that result in modifications to one of the interacting partners. For example, PCNA is involved in both DNA repair and replication Nichols and Sancar, 1992) . Another example is the clamp loader, replication factor C (RFC), which is present in a large complex (BASC) containing the MMR proteins hMSH2, hMSH6, and hMLH1 as well as BRCA1, ATM, BLM, and the RAD50-MRE11-NBS1 complex (Wang et al., 2000) , indicating a physical interaction between the DNA replication factory, the MMR system, and double-stranded break repair. A link between MMR and DNA replication was further supported by experimental data showing that hMSH3 and hMSH6, the partners in MutSb and MutSa complexes, respectively, interact with PCNA (Kleczkowska et al., 2001 ). The nuclear foci of PCNA and other proteins present at the replication fork have been shown to colocalize with sites of newly synthesized DNA (Bravo and MacdonaldBravo, 1987; Leonhardt et al., 2000; Kleczkowska et al., 2001) , and recent studies in bacteria showed that MMR protein MutS colocalizes with DNA polymerase foci (Smith et al., 2001) .
To further characterize the role of hEXO1 in DNA repair and replication, we studied the subcellular localization of hEXO1 and its colocalization with the replication factor PCNA. We demonstrate that hEXO1 associates with PCNA at DNA replication sites and that the C-terminal region of hEXO1 is sufficient for association of hEXO1 with these foci. To clarify the biological role of MMR protein interactions on hEXO1 activity, we carried out in vitro exonuclease assays containing MMR-hEXO1 protein complexes. We show that 5 0 double-stranded exonuclease activity of hEXO1 is inhibited by complex formation with MutLa as well as with MutSa on a homoduplex substrate, but not on heteroduplex DNA. We also show that in pull-down reactions containing hMLH1, hPMS2, and hEXO1, all three proteins are pulled down together, suggesting that MutLa and hMLH1-hEXO1 heterodimers are formed in the reaction mixture. Together, these studies imply that hEXO1 may participate in events at the replication sites and that protein-protein interactions with MMR complexes may regulate human exonuclease 1 activity.
Results

Human exonuclease 1 is upregulated in proliferating cells
We and others have previously shown that hEXO1 is expressed preferentially in tissue containing proliferating cell populations, and is upregulated in colorectal and pancreatic adenocarcinomas (Wilson et al., 1998; Rasmussen et al., 2000a) . Likewise, it has been shown that the human MMR gene hMSH2 is preferentially expressed in proliferating cells (Leach et al., 1996; Marra et al., 1996; Wilson et al., 1998) . In order to investigate the link between the expression of hMSH2 and hEXO1 and cell proliferation in more detail, we synchronized human MMR-proficient SW480 cells using serum starvation to arrest cells in the G1 phase ( Figure 1 ). As expected, both hEXO1 and hMSH2 were highly expressed in exponentially growing cells before serum starvation (Figure 1 , D2/Day 2). When the serum concentration in the growth medium was reduced from 10 to 0.1%, the majority of cells arrested in the G1 phase and significant reductions in both hEXO1 and hMSH2 transcripts were detected (Figure 1 , D9/Day9 and D11/Day11). However, the reduction of the hEXO1 transcript was more evident than for hMSH2. When the cells were released into medium containing high serum, the hEXO1 and hMSH2 transcripts were upregulated (Figure 1 , t24, t30, and t51) and remained high until cells became confluent and arrested in the G1 phase (Figure 1 , t97). Immunocytochemical staining of exponentially growing cells with anti-hEXO1 antibody (Genschel et al., 2002) showed that hEXO1 was almost exclusively located in the nucleus, where it was distributed in 10-20 large foci 1 mM in size (data not shown).
MMR proteins are involved in processing DNA damage caused by alkylating agents, such as N-methyl-N 0 -nitro-N 0 -nitrosoguanidine (MNNG) (Aquilina and Bignami, 2001; Karran, 2001) . It is known that key factors in initializing MMR, like hMSH2 and hMLH1, are required for the recognition of alkylated bases. However, candidate proteins acting downstream of the MutSa and MutLa complexes in the MMR pathway may also be important to complete the processing of alkylation-induced DNA lesions. We therefore examined the expression of hEXO1 after MNNG treatment (Figure 2 ). We found that hEXO1 gene expression is not stimulated by MNNG-induced alkylation damage.
Furthermore, the expression of hEXO1 is unaffected by mutations in hMSH2 (LoVo and LNCaP), hMLH1 (HCT116 and DU145), and hMSH6 (DLD-1) (Figure 2 ). Interestingly, we observe a decrease in hEXO1 expression from a number of samples collected at a late time point (96 h). We have shown that at the late time points, a significant number of the cells are arrested in the G1 phase (data not shown), and that hEXO1 expression is greatly reduced in these cells (Figure 1 ). Therefore, we assume that the lower hEXO1 expression in these samples is a result of high cell density in the tissue culture flasks, and thus little cell proliferation in agreement with the finding that hEXO1 expression is upregulated in proliferating cells compared to G1 arrested cells (Figure 1) .
What is the significance of protein-protein interactions in MMR complexes containing hEXO1?
We have previously shown that the C-terminal region of hEXO1 is required for complex formation with hMSH2 and hMLH1 (Rasmussen et al., 2000a; Ja¨ger et al., 2001) . The interacting regions of hMSH2 with hMSH3 or hMSH6 and hMLH1 with hPMS2 are overlapping with the hEXO1 interacting regions (Kondo et al., 2001; Schmutte et al., 2001) . These findings lead us to examine if hEXO1, hMLH1, and hPMS2 proteins are capable of forming a ternary complex, or whether the hMLH1-hEXO1 complex would exclude other MMR partners in the repair complex (Figure 3a) . We expect that if hMLH1-hEXO1 complex formation excludes hMLH1-hPMS2 heterodimer formation, we would recover only the hEXO1 and hMLH1 proteins following pull-down in the reaction, where we preincubated hMLH1 with hEXO1 followed by addition of hPMS2 (Figure 3a, lanes 3, 5, 7, and 9) . Similarly, we would expect only to recover hMLH1 and hPMS2 in reactions where hMLH1 and hPMS2 were preincubated before addition of hEXO1 ( Figure 3a , lanes 3, 4, 6, and 8). This was not the case, suggesting that hEXO1-hMLH1 or hMLH1-hPMS2 interactions do not necessarily exclude other partners of the MMR complexes. On the other hand, if hMLH1, hPMS2, and hEXO1 are indeed present in a multiprotein complex at the same time, one would expect to recover all three proteins as shown in Figure 3a (lanes 3-9). Thus, we infer that despite the overlapping protein-protein interaction domains, hMLH1, hPMS2, and hEXO1 are capable of forming a protein complex containing all three proteins. In Figure 4 , we show that under the experimental conditions employed in Figure 3a , the GST-hMLH1 proteins, which are bound to the beads, are saturated with the first added protein before the second protein is added to the reaction mixture. However, it cannot be completely excluded that some of the preincubated protein may dissociate and become exchanged with the second protein.
We subsequently examined the significance of the protein-protein interactions in MMR complexes containing hEXO1, since it has been suggested that S. cerevisiae Exo1 plays a structural role in stabilizing MMR complexes as well as an enzymatic role in the degradation of DNA during MMR (Sokolsky and Alani, 2000; Amin et al., 2001; Genschel et al., 2002) . We measured 5 0 double-stranded exonuclease activity of recombinant hEXO1 in the presence of hMLH1 and hMSH2 monomers, and found that the presence of GST fusion protein assay to study the interaction between hMLH1, hEXO1, and hPMS2. Proteins were purified and reactions performed as described in the Material and methods section. (a) Lane 1: GST-hMLH1 and labeled IVTT hPMS2; lane 2: GST-hMLH1 and labeled IVTT hEXO1; lane 3: GST-hMLH1 incubated with labeled IVTT hPMS2 and labeled IVTT hEXO1 protein (hPMS2 and hEXO1 were added to hMLH1 simultaneously); lane 4: GST-hMLH1 incubated for 2 h with labeled IVTT hPMS2 followed by 2 h incubation with unlabeled IVTT hEXO1; lane 5: GST-hMLH1 incubated for 2 h with labeled IVTT hEXO1 followed by 2 h incubation with unlabeled IVTT hPMS2; lane 6: GST-hMLH1 incubated for 2 h with unlabeled IVTT hPMS2 followed by 2 h incubation with labeled IVTT hEXO1; lane 7: GST-hMLH1 protein incubated for 2 h with unlabeled IVTT hEXO1 followed by 2 h incubation with labeled IVTT hPMS2; lane 8: GST-hMLH1 incubated for 2 h with labeled IVTT hPMS2 followed by 2 h incubation with labeled IVTT hEXO1; lane 9: GST-hMLH1 incubated for 2 h with 0 -labeled doublestranded homoduplex DNA substrate (Figure 5a , lanes 3 and 6). To validate the activity of the GST-fusion proteins, we tested cell extracts supplemented with these proteins for their ability to promote the repair of a 2-bp loop substrate that contained a single-stranded nick located 3 0 to the unpaired bases. DNA mismatch repair activity in cell extracts supplemented with GST-hMSH2 Figure 4 GST fusion protein assay to study the interaction between hMLH1 and various amounts of hEXO1 and hPMS2. In total, 50 ng (450 fmol) GST-hMLH1 was added increasing amounts of either labeled IVTT hPMS2 or labeled IVTT hEXO1. (a) Lane 1: GST-hMLH1 and 1 ml labeled IVTT hPMS2; lane 2: GST-hMLH1 and 2.5 ml labeled IVTT hPMS2; lane 3: GST-hMLH1 and 10 ml labeled IVTT hPMS2; lane 4: GST-hMLH1 and 20 ml labeled IVTT hPMS2; lane 5: GST-hMLH1 and 50 ml labeled IVTT hPMS2; lane 6: labeled IVTT hPMS2. (b) Lane 1: GST-hMLH1 and 1 ml labeled IVTT hEXO1; lane 2: GST-hMLH1 and 2.5 ml labeled IVTT hEXO1; lane 3: GST-hMLH1 and 10 ml labeled IVTT hEXO1; lane 4: GST-hMLH1 and 20 ml labeled IVTT hEXO1; lane 5: GSThMLH1 and 40 ml labeled IVTT hEXO1; lane 6: labeled IVTT hEXO1. Samples were resolved on 7% SDS-PAGE gel and imaged using a Phosphoimager fusion protein revealed the following repair activities: wt-22 (19%), wt-22 þ GST-hMSH2 (36%), MSH2À/À (3%), MSH2À/À þ GST-hMSH2 (41%). In a similar assay, MMR activity in cell extracts supplemented with GST-hMLH1 fusion protein revealed the following repair activities:
(15%), HCT116 (26%), and HCT116 þ GST-hMLH1 (22%). Addition of GST-hMLH1 to MMR-proficient HCT116 þ chr3 cell extracts inhibited repair of the heteroduplex, whereas no effect was observed when the fusion protein was added to the MMR-deficient HCT116 cell extract. It is known that MMR activity is inhibited by overexpression of yeast Mlh1 (Shcherbakova et al., 2001) , indicating that our GST-hMLH1 fusion protein is active but not able to complement the repair defect in HCT116 cells. Moreover, overexpression of yeast Msh2 is not mutagenic (Drotschmann et al., 1999) . In agreement with these observations, we found no effect on MMR activity when GST-hMSH2 was added to MMRproficient murine cell extracts. However, when we added GST-hMSH2 to the mMSH2-deficient cell extract, we detected increased repair of the heteroduplex, indicating that the GST-fusion proteins are active. The hMSH6 and hPMS2 proteins used in the exonuclease assays are translated in vitro, which means that these protein preparations contain high amounts of reticulocyte lysates. It is therefore possible that other nucleases are present in these extracts. We incubated the 5 0 -labeled oligonucleotide with IVTT-hPMS2 and IVTT-hMSH6 proteins (Figure 5e ), and show that there are cleavage products originating from nucleases in the reticulocyte lysates. However, these cleavage products are different from the products obtained by the hEXO1 protein and may be the products from a 3 0 hydrolytic activity in the reticulocyte lysates. We do not detect any significant 5 0 hydrolytic activity in the reticulocyte lysates.
We measured 5 0 double-stranded exonuclease activity of recombinant hEXO1 in the presence of either one of the heterodimers MutSa or MutLa. We found that the presence of both heterodimers in the reactions completely inhibited 5 0 double-stranded exonuclease activity of hEXO1 in vitro on the perfectly matched substrate (Figure 5a, lanes 4, 5, 7, and 8) . In contrast, addition of either one of the heterodimers MutSa or MutLa did not inhibit 5 0 double-stranded exonuclease activity of hEXO1 in vitro on a substrate containing a G/T mismatch (Figure 5b, lanes 4, 5, 7, and 8) . These data support recent findings that excision of strand breaks in vitro requires the MutSa and MutLa complexes on gapped mismatch containing DNA substrates (Genschel et al., 2002) .
Colocalization of human exonuclease 1 with PCNA and hMLH1
Many proteins involved in DNA metabolism have been observed in discrete foci in the nucleus (Celis and Celis, 1985; Hozak et al., 1993) . Since hEXO1 was highly expressed in replicating cells (Figure 1) , we examined the colocalization of hEXO1 with PCNA by confocal laserscanning microscopy. Cells were cotransfected with CFP-PCNA and YFP-hEXO1 encoding blue and yellow fluorescent fusion proteins of PCNA and hEXO1, respectively, and visualized simultaneously by two-color confocal imaging (Figure 6 ). Two different YFP-hEXO1 patterns were observed in cells cotransfected with YFPhEXO1 and CFP-PCNA: either (i) distinct nuclear foci or a (ii) diffuse nuclear staining (Figure 6 ). The diffuse nuclear staining is observed in cells that are not in the S phase as judged by the absence of PCNA foci (Figure 6) . Furthermore, the diffuse nuclear staining pattern is not detected with the exonuclease antibody staining (data not shown). The difference between these conditions is that YFP-hEXO1 expression is under control of a CMV promoter that is constitutively active. In this way, the diffuse staining is likely to result from the absence of PCNA in non-S-phase cells. In cells where YFP-hEXO1 was present in foci, there was a clear colocalization with PCNA, indicating that hEXO1 is associated with replication foci in cells undergoing DNA synthesis (Celis and Celis, 1985; Fuss and Linn, 2002) . We were not able to detect any protein-protein interactions between hEXO1 and PCNA using the yeast two-hybrid system (data not shown), indicating that the proteins do not associate directly.
The human exonuclease 1 interacts with other MMR proteins through the C-terminal but not the N-terminal region of the proteins (Rasmussen et al., 2000a; Ja¨ger et al., 2001; Schmutte et al., 2001) . We therefore investigated whether the C-terminus of hEXO1 played a role in the formation of nuclear foci with PCNA. We found that cells expressing both PCNA and the Cterminal region of hEXO1 colocalized to discrete foci in the nucleus, whereas cells expressing PCNA and the Nterminal region of hEXO1 did not ( Figure 6 ). Finally, we examined if the hEXO1 and PCNA complexes colocalized with the mismatch repair system by transfecting the cells with CFP-hMLH1 and YFP-hEXO1 before they were fixed, and endogenous PCNA was immunostained with an anti-PCNA antibody (Figure 7) . The simultaneous three-color imaging showed that all three proteins were contained in discrete foci as shown for hEXO1 and PCNA. Taken together, these results in combination with the results presented in Figure 1 , showing that hEXO1 is highly expressed in S phase, suggest a role for human exonuclease 1 in events occurring in association with DNA replication.
Discussion
Eukaryotic proteins are often components of larger complexes and the disruption of protein-protein interactions might affect several different cellular processes. Furthermore, many eukaryotic genes show tissuespecific expression, including human exonuclease 1, indicating that the composition of protein complexes might vary among different cell types and tissues. To emphasize the complexity of eukaryotic MMR, it has been shown that mice carrying disruptions of specific MMR genes display a variety of phenotypes ranging from tissue-specific tumorigenesis to sterility (Baker et al., 1995 de Wind et al., 1995 de Wind et al., , 1999 Reitmair et al., 1995; Edelmann et al., 1996 Edelmann et al., , 1997 Edelmann et al., , 2000 Prolla et al., 1998; Heyer et al., 1999) . Along these lines, it is known that MMR proteins are involved in several cellular processes such as repair, homeologous recombination, homologous recombination, as well as cell cycle control following DNA damage by alkylating agents (Modrich and Lahue, 1996) .
The human exonuclease 1 forms a complex with the MMR proteins hMSH2 and hMLH1, and we find that the hMLH1 and hMSH2 monomers as well as the heterodimers MutSa or MutLa inhibit hEXO1 activity on a 5 0 -labeled double-stranded homoduplex DNA substrate. In contrast, either one of the heterodimers MutSa or MutLa does not inhibit 5 0 double-stranded exonuclease activity of hEXO1 in vitro on a substrate containing a G/T mismatch. It has recently been reported that the excision activity of strand breaks in vitro requires the MutSa and MutLa complexes on mismatch containing DNA substrates (Genschel et al., 2002) . In the human MMR pathway, a mismatch is first recognized and bound by either the MutSa or the MutSb complex. Our results suggest a role for human exonuclease 1 in MMR downstream the initial mismatch recognition step. We propose that hEXO1 is one exonuclease in the MMR process and that the nuclease activity of hEXO1 is controlled by complex formation with MutSa and MutLa complexes. However, MMR proteins have also been shown to inhibit DNA recombination by inhibiting strand-transfer (Worth et al., 1994) and biochemical as well as genetic experiments have provided evidence that Figure 6 Nuclear localization of CFP-PCNA, YFP-hEXO1-N, YFP-hEXO1-C, and YFP-hEXO1 fusion proteins. NIH-3T3 cells were transiently transfected with 2 mg/ml of each constructs. Cells were incubated overnight before the distribution of YFP-hEXO1, YFP-hEXO1-C, or YFP-hEXO1-N together with CFP-PCNA was examined by confocal laser scanning microscopy. The right panels show the corresponding outline of the cells in Nomarski contrast exonuclease 1 plays an important role in DNA recombination. As MutSa and MutLa heterodimers inhibit 5 0 to 3 0 exonuclease activity of hEXO1, it could be prevented from establishing recombination intermediates by generating single-stranded tails required for strand-transfer during recombination. The fact that hMSH2 and hMLH1 monomers do not efficiently inhibit hEXO1 5 0 to 3 0 exonuclease activity on doublestranded DNA substrates could have important implications for HNPCC individuals carrying mutations in the hMSH6 and hPMS2 genes. It is likely that some of the hMSH6 and hPMS2 missense mutant proteins found in colon cancer patients are expressed, but imperfect in generating heterodimers with hMSH2 and hMLH1. If so, one would expect that the hMSH2 and hMLH1 monomers form a complex with hEXO1, but in the absence of MutSa and MutLa the hEXO1 exonuclease activity is not strictly controlled. This could result in defects in MMR activity, recombinational activities, as well as other cellular functions involving MMR proteins such as apoptosis.
Expression analysis of PCNA during cell cycle showed that PCNA was absent in G0/G1 cells, increased from the S phase of the cell cycle, and was rapidly degraded at the end of the G2 phase (Kawamura et al., 2000) . The localization of PCNA during the S phase has been well documented (O'Keefe et al., 1992; Leonhardt et al., 2000; Kleczkowska et al., 2001; Somanathan et al., 2001) . Early S phase is characterized by many small, well-distributed foci that become larger as the S phase progresses until a few large foci are observed late in the S phase. We show that hEXO1 colocalizes with PCNA in both small and large foci, indicating that these proteins are associated during the entire S phase, and we therefore assume that the hEXO1 protein is associated with the replication complex. A similar pattern has been reported for the eukaryotic Ssb protein RPA, which has been suggested to play a role in MMR (Bre´not-Bosc et al., 1995; Lin et al., 1998) . As the C-terminal domain of hEXO1 is critical for this colocalization, proteinprotein interactions between hEXO1 and PCNA could play an important role in connecting the MMR process to DNA replication.
It has been suggested that S. cerevisiae Exo1 plays a structural role in stabilizing MMR complexes in addition to an enzymatic role in the degradation of DNA during MMR (Sokolsky and Alani, 2000; Amin et al., 2001) . Both these models are consistent with our results. It is possible that the presence of hEXO1 in the MMR complexes is needed to stabilize a multiprotein complex at the sites of DNA replication. Alternatively, hEXO1 is recruiting or directing MMR proteins to the replication complex and ensuring that the MMRreplication complexes only assemble during DNA replication. The other function of hEXO1 would be to carry out exonucleolytic degradation of repair intermediates during the MMR process. In this scenario, hEXO1 activity must be tightly controlled to prevent the exonuclease from acting on gaps and breaks generated during DNA synthesis. For example, during lagging strand synthesis, 5 0 gaps are generated after primer removal by the Fen1 protein. Based on mutational analysis of yeast Exo1, this exonuclease could function as a backup for Fen1 in RNA primer removal during lagging strand DNA synthesis (Tran et al., 2002) . Furthermore, the 5 0 gaps generated during lagging strand synthesis would be substrates for nucleolytic degradation by exonuclease 1. Therefore, the cell must have mechanisms to ensure that exonuclease 1 is not degrading the DNA template unless it contains a mismatch or unpaired bases. This could be regulated by protein-protein interactions between the MutSa and MutLa complexes and hEXO1, ensuring that exonucleolytic degradation of DNA by hEXO1 is only activated after MMR is initiated.
Our results imply a role for hEXO1 in events occurring in association with DNA replication such as MMR. However, the expression patterns and biochemical activities of hEXO1 suggest a role for the nuclease in recombination. Along these lines, we have shown the existence of MMR-controlled hEXO1 activity on substrates resembling double-stranded breaks or doublestranded ends. DNA replication pausing or stalling can be caused by gaps or DNA lesions, but can also occur naturally at secondary structures in DNA (Rothstein et al., 2000) . Stalling of replication forks generates double-stranded ends that are substrates for recombination, and it is known that recombination proteins act during replication and upon replication pause (Michel et al., 2001) . Werner syndrome is a hereditary disease in humans that is caused by a dysfunctional WRN protein that has a 3 0 to 5 0 exonuclease activity. The WRN protein interacts with several components of the DNA replication complex, such as DNA polymerase d, PCNA, RPA, hEXO1, and Fen1, and it has been proposed that WRN plays a role in restarting of stalled replication forks (Kamath-Loeb et al., 2001; Lebel, 2001; Sharma et al., 2003) . The human exonuclease 1 can act on substrates resembling double-stranded ends Figure 7 Colocalization of hEXO1, hMLH1, and PCNA. Cells were transfected with CFP-hMLH1 and YFP-hEXO1 before they were fixed and endogenous PCNA was immunostained with a mouse anti-PCNA antibody and an Alexa deep-red secondary antimouse antibody, so all three proteins could be imaged simultaneously by three-color confocal imaging and could for that reason be involved in restarting of stalled replication forks and/or recombinational events occurring at stalled replication complexes.
In summary, our results show that hEXO1 and PCNA form discrete foci that assemble at DNA replication sites, and that the C-terminal region of hEXO1 is sufficient for the formation of these foci. The exonuclease activity of hEXO1 is regulated by complex formation with MutSa or MutLa. The results presented in this study support a model in which hEXO1 plays a role in formation/stabilization of MMR complexes at the replication sites as well as a functional role in the MMR process.
Materials and methods
Cell culture and preparation for immunofluorescence microscopy and flow cytometry Murine NIH-3T3, wt-22, and MSH2À/À cells were maintained as monolayer cultures in DMEM (Gibco, Life Technologies) supplemented with 10% FBS and 1% penicillin-streptomycin (Gibco, Life Technologies). On the day of treatment, NIH-3T3 cells were transiently transfected with 3.5 mg DNA, incubated overnight at 371C in a humidified 95% air-5% CO 2 atmosphere, and confocal laser scanning microscopy examined the subcellular localization of the fusion proteins the next day. The human colon cancer cell lines SW480, HCT116, and HCT116 þ chr3 were maintained in culture as adherent cells in McCoy's 5A medium containing 10% FBS and 1% penicillin-streptomycin, and the growth medium was changed every 2-3 days (GibcoBRL, Life Technologies). HCT116 þ chr3 cells were supplemented with 200 mg/ml G418 to retain the extra chromosome 3 in the cells. Cells were grown at 371C in a humidified 95% air-5% CO 2 atmosphere. For synchronization, SW480 cells were seeded in 14 tissue culture flasks on day 1 and allowed to attach overnight. The next day (day 2), two of the flasks were removed and cells were harvested for RNA preparation and FACS analysis. This was repeated on day 9. The growth medium in the remaining flasks was shifted to a medium containing 0.1% FBS and incubated for 60 h. After incubation, two flasks were removed for sample analysis (day 11), and the cells in the remaining flasks were treated with trypsin, diluted 1 : 10, and shifted back to a growth medium containing 20% FBS. Cells were incubated and samples for RNA preparation and FACS analysis were taken after 24 h (t24), 30 h (t30), 51 h (t51), and 97 h (t97). The cell cycle distributions were analysed by flowcytometry as described in Rasmussen et al. (2000b) and RNA was isolated as described in Northern blot analysis.
Plasmids
Plasmid pLJR115 (YFP-hEXO1) was constructed by inserting a PCR fragment containing the human hEXO1b cDNA into the BamHI and SalI sites of the pEYFP-C1 (CLONTECH) vector and plasmid pACJ112 (CFP-hMLH1) by inserting the hMLH1 cDNA into the EcoRI and BamHI sites of the pECFP-C2 vector (Ja¨ger et al., 2001) . Plasmid pACJ134 (CFP-PCNA) was constructed by inserting the human PCNA cDNA (Leonhardt et al., 2000) into the XhoI and BamHI sites of pECFP-C1 (CLONTECH). Plasmid pLJR117 (YFP-hEXO1-N) contains a C-terminal truncation of the hEXO1 gene fused to EYFP, and was constructed by digesting pLJR115 with ScaI and BamHI followed by Klenow treatment and religation of the plasmid. This generates a fusion protein containing the first 394 amino acids of hEXO1 fused to YFP. Plasmid pLJR116 (YFP-hEXO1-C) contains an N-terminal truncation of the hEXO1 gene fused to EYFP and was constructed by digesting pLJR115 with ScaI and XhoI followed by Klenow treatment and religation of the plasmid. This generates a fusion protein containing the final 443 amino acids of hEXO1 fused to EYFP. All fluorescent protein constructs are N-terminal fusions.
The fragments were amplified by PCR using primers containing additional restriction enzyme sites as indicated. Primer pairs pLJR115 (5
Northern blot analysis
For detection of transcripts in synchronized human SW480 cells, aliquots (20 mg) of total RNA (RNAqueous TM , Ambion) were run on 1% agarose/0.2 M formaldehyde gels and immobilized onto nylon membranes. All probes were labeled by random primer extension (Rediprime DNA labeling system, Amersham Pharmacia Biotech) and [a- 32 P]dCTP (Amersham Pharmacia Biotech) using a PCR product as a template. For detection of transcripts, the blots were probed with a 946-bp fragment containing the C-terminal region of hEXO1 (hEXO1 probe). This probe was generated by PCR primers 5 0 -GAGTGTAAGCACTCCACCTAGG-3 0 and 5 0 -CCCGGCTTGTTCTCGGCATTAT-3 0 . For detection of hMSH2, the blots were probed with a 1054-bp fragment containing the N-terminal region, which shows limited homology to other known MutS homologs. This probe was generated by PCR primers 5 0 -GTGCGCTTCTTTCAGGG CATGC-3 0 and 5 0 -TTATTCAGCAAGGCAGCCAGAG-3 0 (hMSH2 probe). All membranes were hybridized with 1 Â 10 6 cpm/ml of 32 P-labeled probes. The membranes were prehybridized for 30 min at 681C and hybridized for 90 min at 681C in QuikHyb s Hybridization Solution (Stratagene). Blots were washed twice at room temperature for 15 min and once at 601C with wash solution (1 Â SSC, 0.1% SDS). Images were obtained using autoradiography. The GAPDH and actin probes were purchased from CLONTECH and prepared as described above and used to correct for differences in loading.
Preparation of DNA substrate
We used a 42 bp 5 0 -labeled double-stranded homoduplex substrate (A2/A9) described in as well as a corresponding heteroduplex (A2(G23)/A9) substrate containing a G/T mismatch at position 23. The top strand oligonucleotides (A2 or A2(G23)) were labeled on the 5 0 -end using T4 polynucleotide kinase and [g-32 ]ATP. Excess ATP was removed by using NucTrap s Probe Purification Columns (Stratagene), and the labeled strand was annealed to an equal molar concentration of the complementary oligonucleotide (A9) in 20 mM Tris-HCl pH 7.6, 0.01 mM EDTA, 0.1 mM DTT by heating to 701C for 10 min, followed by cooling to RT for 30 min and finally incubated on ice for 5 0 . The nucleotide sequences of the oligonucleotides areas follows: (A2) 5 0 -TAG AGG ATC CCC GCT AGC GGG TAC CGA GCT CGA ATT CAC TGG-3 0 , (A2(G23)) 5 0 -TAG AGG ATC CCC GCT AGC GGG TGC CGA GCT CGA ATT CAC TGG-3 0 , and (A9) 5 0 -CCA GTG AAT TCG AGC TCG GTA CCC GCT AGC GGG GAT CCT CTA-3 0 .
Exonuclease assays
Nuclease assays were performed essentially as described by with few modifications. The reactions contained various amounts of purified hEXO1 recombinant protein (0, 0.001, 0.01, 0.1, 1, 5, and 10 pmol), hMSH2, hMSH6, hMLH1, hPMS2, and 0.25 pmol end-labeled DNA substrate in a final volume of 40 ml containing 20 mM HEPES pH 7.5, 50 mM KCl, 0.5 mM DTT, 5 mM MgCl 2 , 0.05% Triton X-100, 100 mg/ml BSA, and 5% glycerol. The hMSH2 and hMLH1 proteins were purified as GST-fusion proteins and the hMSH6 and hPMS2 proteins were synthesized in vitro as described in Ja¨ger et al. (2001) . The hMSH2 and hMSH6 as well as hMLH1 and hPMS2 proteins were preincubated at 371C for 60 min to allow heterodimer formation before the proteins were added to the reaction mixture. Reactions were carried out at 371C for 60 min and stopped immediately by adding 8 ml of formamide loading buffer and heating at 901C for 5 min. Aliquots were subsequently analysed on a 12% 8 M polyacrylamide urea denaturing gel to determine the degree conversion of substrate to mononucleotide product. Images were obtained using a STORM 840 Phosphoimager (Amersham Pharmacia Biotech).
Purification of hEXO1
Recombinant hEXO1 (hEXO1b) protein was expressed using the Insect s Select system (Invitrogen). High Five s cells were cultured in High Five s serum-free medium (Invitrogen) at 271C and split 1 : 5 upon passage. The hEXO1 cDNA was cloned into the baculovirus vector pFastBac H6 (Invitrogen) and was kindly provided by Dr David M Wilson III (NIA, USA). The DNA used for transfection was purified using Jet Star 2.0 Maxi kit (Genomed). On the day of transfection, 2 Â 10 6 exponentially growing High Five s cells were transfected with 1 mg DNA using Insectin-Plus s (Invitrogen). Stably transfected cells were selected using 500 mg/ml Zeocin (Invitrogen) over a 2-week period. Recombinant protein was harvested from cells growing in High Five s serum-free medium added Zeocin. The His-tagged hEXO1 recombinant protein was purified using the ProBondt Purification System, according to the manufacturer's guidelines (Invitrogen). In brief, cleared supernatant was loaded onto a pre-equilibrated column under native binding conditions, and eluted with four different imidazole elution buffers, with increasing imidazole concentrations (50, 200, 350 , and 500 mM). The hEXO1-containing fractions, which eluted at 50 mM imidazole, were pooled and the hEXO1 protein visualized by Western blotting using an antibody (SC-803, Santa Cruz) that recognized the His 6 epitope in the recombinant protein. It should be noted that the fraction containing exonuclease activity contained both a polypeptide corresponding to full-length hEXO1 (94 kDa) as well as a smaller 50 kDa polypeptide. It has been reported that that exonuclease 1 from S. cerevisiae also coeludes with a smaller protein of 42 kDa (Fiorentini et al., 1997) . We assume that the 50 kDa polypeptide copurifying with full-length hEXO1 is the N-terminal region of hEXO1 since this polypeptide is recognized by the His 6 -antibody.
Pull-down assay
All in vitro transcription translation reactions were carried out using the TNT coupled reticulocyte lysate system (Promega). Briefly, lysates were incubated with 1 mg of DNA, amino-acid mix lacking cysteine, 35 S-Cysteine and T7 RNA polymerase, for 90 min at 301C, according to the manufacturer's instructions. The fusion proteins were purified as described by Ja¨ger et al. (2001) , using non-induced E. coli cultures. The pull-down assays were performed essentially as described by Ja¨ger et al. (2001) with a few modifications. In brief, the GST-hMLH1 protein was bound to beads and preincubated for 2 h with either IVTT-hPMS2 or IVTT-hEXO1. The protein-bound beads were washed three times with a binding buffer and the second protein was added to the reaction mixture and incubated for 2 h at 41C before the reaction mixtures were washed and loaded on the gels. The standard reactions contained 50 ng (450 fmol) GST-hMLH1, 200 ng (2 pmol B10 ml) hPMS2, and 200 ng (2 pmol B10 ml) hEXO1 proteins. Samples were resolved on 7% SDS-PAGE gel and imaged using a Phosphoimager. The values for relative band intensities were determined using the Tina 2.0 software.
Immunohistochemistry and confocal laser-scanning microscopy Immunocytochemistry was performed as described before (Nielsen et al., 1999) . Briefly, NIH-3T3 cells were plated on glass dishes. The cells were fixed in methanol, washed, and incubated with 10% goat serum before hEXO1-specific antibodies (Genschel et al., 2002) were added for 60 min at 201C in PBS with 0.5% Tween. After the cells were washed, they were incubated with TRITC-conjugated goat anti-rabbitIgG for 30 min at 201C and mounted in 90% glycerol with 0.25% 1,4-diazabicyclo[2.2.2]octane. For control stainings, the specific antibody was replaced with rabbit serum. Transient transfections of CFP-PCNA, CFP-hMLH1, and YFP-EXO1 were performed with LipofectAMINE2000 (Life Technologies Inc., USA), according to the manufacturer's instructions. Briefly, 30 000 cells/cm 2 were seeded on glass plates 24 h prior to transfection. Cells were transfected with 2 mg/ml of the relevant plasmid and left for 24-48 h before the CFP-or YFP-proteins were examined with a confocal Zeiss LSM510 microscope, as described (Nielsen et al., 2002) .
DNA mismatch repair assay
Cytoplasmic cell extracts of HCT116 and HCT116 þ chr3 cells and heteroduplex were prepared as described in Thomas et al. (1995) . The heteroduplex (2O-3 0 at 90-91) used in this study contains two unpaired bases at position 90-91 in the lacZ complementation gene (2 bp loop, 2O) and a 3 0 -nick in the (À) strand at the AvaII site. Each repair reaction (total volume 126 ml) contained 30 mM HEPES pH 7.8, 15 mM sodium phosphate pH 7.5, 7 mM MgCl 2 , 4 mM rATP, 200 mM each rCTP, rGTP, rUTP, 100 mM each dATP, dCTP, dGTP, and dTTP, 40 mM creatine phosphate, 100 mg/ml creatine phophokinase, 10 ng heteroduplex, and 500 mg cell extract. When indicated, the repair reactions were added 5 ng purified GSTtagged hMLH1 fusion protein. The reaction was incubated 1 h at 371C. Plaques were scored after at least 20 h of incubation at 371C. Repair activity is calculated as (1 -the ratio of the percentages of mixed plaques obtained from treated and untreated substrates). The results are based on counting more than 300 plaques and one representative experiment is shown. Blue/white ratios of plaque color confirmed that repair was directed to the nicked strand (data not shown).
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